A system for and method of detecting and measuring concentrations of an ultrasonically-reflective microsphere contrast agent involving detecting non-linear sum and difference beat frequencies produced by the microspheres when two impinging signals with non-identical frequencies are combined by mixing. These beat frequencies can be used for a variety of applications such as detecting the presence of and measuring the flow rates of biological fluids and industrial liquids, including determining the concentration level of microspheres in the myocardium. Ultrasonically-reflective microsphere contrast agents are used in medical ultrasonic imaging to enhance the image obtained by increasing the contrast of and outlining the anatomic structures being studied, for example the heart (its chambers, blood vessels, and tissue). An example of such an agent is Albunex, available from Molecular Biosystems, San Diego, Calif. Microsphere contrast agents are also used to ultrasonically assess adequacy of blood flow (i.e., perfusion) to the heart muscle (Le., myocardium). Assessment of perfusion allows determination of the existence or risk of a myacardial infarction (Le., a heart attack), in which the heart muscle dies because of blockage by plaque of the blood vessels supplying it.
Currently, microsphere contrast agents must be injected directly into the arteries of the heart muscle in order to be dctectable with conventional ultrasonic scanners (via video intensity) and to thereby allow assessment of myacardial perfusion. Consequently, this technique is available only during cardiac surgery or catheterization. Non-invasive procedures such as peripheral intraveneous injection of the microspheres are desirable. However, dilutional effects and trapping of the larger, more reflective microspheres by the lung circulation lowers the effective microsphere concentration to such a degree that conventional ultrasonic scanners can no longer detect them in the myacardium.
Monaghan (U.S. Pat. No. 5,255,683) discloses a method of microsphere detection based on a shift in the radiofrequency (RF) spectrum of the ultrasonic myocardial echo when microspheres are present. This method is used to assess myocardial perfusion in patients. This spectral shift method does not involve the mixing of two frequencies by the microspheres with a subsequent emission of a third frequency by the microspheres. The method disclosed by Monaghan is only a qualitative detector of microsphere prescnce or absence. It does not allow quantitative estimation of thc microsphere level in the myocardium and thus has limited usc in assessing myocardial perfusion.
Shropc et al. in Ultrasonic Imaging 14(2), April 1992, investigated a method of detection based on generation by the microspheres of an RF second harmonic of the transmitted scanner frequency. As the second harmonic generated by the myocardium is of much lower magnitude, presence of the harmonic correlates with presence of the microspheres. Microsphere level in the myocardium per unit time can thus bc measured and myocardial pcrfusion derived. 
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SUMMARY OF THE INVENTION
In accordance with one aspect of the present invention, a method and system for ultrasonically examining tissue using an ultrasonically-reflective microsphere contrast agent detects the presence of ultrasonic beat frequencies generated by the presence of the microspheres.
More specifically, in accordance with this aspect of the present invention, a method of examining tissue using ultrasonically-reflective microsphere contrast agents detects non-linear sum and difference beat frequency signals which are produced when two signals with non-identical frequencies are combined by mixing. The amplitude of these beat frequencies is used to determine the concentration level of the microspheres in the myocardium. In the myocardium, the microspheres act as non-linear ultrasonic mixers when impinged upon by two or more ultrasonic waves of different frequencies. The microspheres re-radiate both the impinging frequencies, but in addition they generate non-linear difference and sum frequencies. This non-linear effect is significantly greater when one or both impinging frequencies approximates the resonant frequency of the microspheres. Myocardial tissue, on the other hand, reflects the two original frequencies since the myocardium does not generate substantial amplitudes of sum or difference frequencies.
To produce the beat frequencies, an insonifier transducer instills ultrasonic energy into a patient's chest at a prescise single frequency, ideally the resonant frequency of the microspheres. A scanner transducer also instills ultrasonic energy into the patient's chest at a single frequency, but the scanner frequency is different than that of the insonifier. In addition, the scanner receives and processes the ultrasonic echo and generates a video image. The beat frequency signal due to the microspheres in the myocardial region of interest is detected within the overall echo signal. A plot is then generated of the microsphere signal level vs. time, which in turn correlates with myocardial perfusion. Myocardial perfusion parameters are derived such as: time to peak of curve, time to half peak (ascending and descending portions of curve), half-time point slopes, time of appearance of contrast agent, and area under the curve.
The present invention permits the detection of the relatively small level of microspheres passing through the myocardium per unit of time after peripheral intraveneous injection. In addition, the present invention derives myocardial perfusion parameters from this data. Advantages of the present invention include both the ability to quantitatively detect small levels of microspheres in heart tissue and the ability to use this method with all types of microsphere and microbubble contrast agents. detected within the overall echo signal. A plot is then generated of the microsphere signal level vs. time, which in turn correlates with myocardial perfusion. A computer 100 controls the operation of the system, plots microsphere concentration vs. time, and derives myocardial p e r h i o n parameters. Such perfusion parameters would include: time to peak of curve, time to half peak (ascending and descending portions of curve), half-time point slopes, time of appearance of contrast agent, and area under the curve. FIG. 2 illustrates a typical frequency amplitude versus time curve from which perfusion parameters can be derived.
The present invention uses ultrasonic beat frequencies generated by the injected microspheres 95 to detect their presence and concentration level in the myocardium 98.
l5 DESCRIPTION OF THE PREFERRED EMBODIMENTS
Beat frequencies are produced when two signals with nonidentical frequencies are combined by mixing. Non-linear sum and difference frequencies result, according to the Referring to FIG. 1 , the insonifier transducer 10 instills 2o followi% trignometric identity: ultrasonic energy into a patient's chest 15 at the resonant frequency of the microsphere contrast agent, e.g., 1.3 MHz for Albunex. The term microsphere as used in this specifi-
Cos(A)Cos(B)=%Cos(A+B)+%Cos(A-B)
cation should be understood to include the Use Of microbubbles. The insonifying signal generator 20, is amp1ified by the RF power amp1ifier 30, and is then fed to the insonifying transducer lo. The
Referring to FIGS, 3 and 4, in the myocx~ium 98, the Originates from a 25 microspheres 95 act as non-linear ultrasonic mixers when impinged upon by two or more ultrasonic waves of different frequencies, The microspheres re-radiate both the insonifyscanner transducer 40 also instills ultrasonic energy into the frequency is different than that of the insonifier. The inter-3o increases section Of the two beams Of form an intersection volume which, in this example corresponds to a that are used in medical applications are 1.0 MHz to 5.0 ing and the Scanner frequencies, but in addition they genwhen the insonifying frequency is near the microsphere resonant frequency . FIG. 3 such that attenuation of the ultrasonic wave is not an 4o sum or difference frequencies, Myocardial generation of significant sum and difference frequencies would occur only i[ the insonifying frequency were near the myocardium also receives and processes the ultrasonic echo and generates a video image. The received image is used to locate a frequency,
To determine the concentration of the microspheres, conregion Of interest to evaluate myocardial perfusion by Of the microsphere detection method Of the present 45 sider two intersecting beams, one with a frequency f, and the other with frequency f,, as illustrated in FIG, 4 . The purpose of the measurement is to determine at any instant the tion.
Although the present invention is illustrated in reference to circulation dynamics Of artend blood flow in myocardial concentration of microspheres in the insonified region, which is defined geometrically by the volume intersection or tissue, this apparatus and mcthod has broader application to 50 interaction volume of the two beams. Each microsphere in body Organ, body tissue Or body fluid where alteration the interaction volume will respond by generating the mixin fluid Or tissue dynamics is central to the Pathology under ing components of the two frequencies, f, and f2 (f,+f,, investigation. For example, with the use of suitable microfl-f2, zf,, 2f,, and to a lesser extent, 3f,, 3f2, and other spheres, the present invention Can be used to monitor blood non-linear products). n e magnitude of the received signal flow patterns in the brain Of stroke patients, tumors, rCtina1 55 of each mixing component depends upon A,, the amplitude blood flow in the eye, tissues affected by pressure ulcers, and of f,, A,, the amplitude of f,, the total number of microblood Perfusion of tissue in P a ofthe human body, spheres in the insonified region, and the microsphere mixing including muscle and tendon tissue. Additionally, the invenefficiency, which depends upon microsphere properties (e,g,, tion can be used to enhance images of fluids and tissue in any resonance) and acoustic wavelengths, amplitudes, frequenpart of the body. The beat frequency signal image Can be 60 cies and phase relationships. superimposed on conventional scanning images to reveal With known drive amplitudes A, and A,, one can use a anatomy not otherwise visible to clinicians. direct measurement with a calibrated (receive) transducer
The interface electronics consist of a mixer 50, two and knowledge of the tissue attenuations in the respective lowpass filters 70 and 72, a signal amplifier 80, and a lock-in insonifying beam paths to determine the concentration of amplifier 90. When microspheres 95 are injected into the 65 microspheres in the interaction volume. One way is to patient and reach the myocardium 98, the signal duc to the develop a tissue phantom which is placed between the drive microspheres 95 in the myocardial region of interest is transducers and the difference frequency sensing device.
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When the drive transducers are activated with specific drive wavcforms, thc calibration is made from measurements of thc mixcd frcquencies from a known concentration of microsphcrcs in thc interaction volume. With a determination of thc sizc of thc insonified volume in the patient, the only s unknown is the actual microsphere concentration, which therefore can be calculated from measurement and comparison with the calibration results. The larger the amplitude of the in, sonifying waves, the greater is the amplitude of the detected wave and therefore the quicker the scan that can be IO performed.
Thc frequcncy fl-f2 would be the lowest frequency component, and hence it would most likely be the most easily reccivcd of thc mixing components, since it would be the least aected by tissue attenuation. Therefore, it will be used 1s to illustrate thc present invention, although any mixing component could be used. Once the difference frequency is gcncratcd, it must traverse the tissue between the generating microsphere and the transducer or transducer array. The output from this transducer is analyzed to determine micro-20 sphcre concentration. This analysis can be done by computer algorithm or other analytical means. The microspheres in the interaction volume of the two ultrasonic waves, each wave at its respective drive frequency, will be appropriately acti-
The frequencies f, and f2 are chosen (1) so that either f, or f2 approximates the resonant frequency of the microspheres but differs from the resonant frequency of the tissue to bc examined and (2) so that the output of the difference frequency receiver transducer is maximized. Other consid-30 erations which affect the decision are tissue attenuation to fi and f2, distance of activation volume from the f, and f2 drive transducers, location of the difference frequency transducer, and the efficiency of microsphere generation of the differFor example, if one is examining a region near the junction of muscle fibers to the tendon which attaches the muscle to the bone, the drive transducers could be spaced 60" apart on the arc of a circle where the area under cxamination is located at the center. The receiver transducer, 40 sensitive to the difference frequency fl-f2, can be placed on the same circle but located 150" from either insonifying transducer. Under these conditions, the ultrasonic waves generated by the insonifying transducers intersect at the area in question and the wave of frequency f,-f microspheres will propagate from the insonified volume at the center of the circle to the receive transducer. The output of the receive transducer is then proportional to the concentration of microspheres within the insonified volume.
transducer is chosen to optimize the sensitivity to the drive frequcncy. The order of importance in selecting the drive frcquencies will be largely determined by the particular application. For example, if the region to be examined is approximately 5 cm deep and the receive transducer is 55 placed directly below the area of examination, the following factors will be important in selecting the drive frequencies: (I) the efficicncy of mixing of the two insonifying ultrasonic waves by the microspheres, (2) the attenuation of neighboring tissue through which the insonifying ultrasonic waves 60 must pass to reach the interaction volume, (3) the depth of thc interaction volume from the drive transducers, and (4) an acccptablc sitc location for the receive transducer.
A high-gain, extremely narrow-band amplifier circuit 90 (lock-in amplifier) detects precisely the difference frequency 65 gcneratcd by the microsphercs 95. It does this by comparing the incoming RF signal to an exact difference reference After the selection of the drive frequencies, the receive 50 signal derived from electronically mixing the scanner transmit frequency and the chest insonifying frequency and lowpass filtering the result. The incoming RF echo signal contains both the myocardial tissue signal and the microsphere-generated signal consisting of the scanner, insonifying, sum and difference signals. The incoming RF echo signal also contains noise. A lowpass filter 72 is used to allow passage of only the difference frequency and the low frequency component of the noise to the lock-in amplifier circuit input. The lock-in amplifier circuit function can be understood by the following:
Let: Acos(X)=electronically-generated difference signal (reference signal) [Bcos(Y)+n(t)]=microsphere-generated difference signal (desired signal) plus noise, which constitutes the lowpass filtered incoming RF signal. The lock-in circuit 90 first electronically mixes the lowpass filtered incoming RF signal with the reference signal:
Acos(X)[BCos(Y)+n(t)]=MBCos(X+Y)+YdBCos (X-Y) +n(t)Ac o s m
If X=Y, then:
Lowpass filtering the result gives:
=%AB
Le., a DC value which is proportional to the amplitudes of the reference signal and the desired microsphere signal. If the reference amplitude is held constant, then the result is a DC value proportional to only the microsphere-generated difference signal. The lock-in amplifier circuit 90 can detect the microsphere signal even when the incoming RF signal is highly contaminated with noise of much greater amplitude. The lock-in function can be accomplished by either analog or digital (i.e., software) means. The output of the lock-in amplifier 90 consists of the amplitude of the microsphere difference frequency detected. Detection of the signal due to the microspheres is thus possible even at very low concentrations such as in the myocardium after peripheral intravenous injection.
Referring to FIG. 5 , only a portion of the RF sector scan lines is analyzed, corresponding to the region of interest in the myocardium. Peaks corresponding to the transducer burst 120, anterior wall echo 130, and the posterior wall echo 140 are present in both scans. However, only the scan in which the contrast agent is present indicates microsphere RF echos 150.
Refemng to FIG. 6 , since f, and f2 are relatively close to each other, it is possible to use a single transducer 110. The intersection volume here is a cylinder 105 coaxially located beneath a single drive transducer. For this application it is possible to form an electrical drive signal by employing a summing circuit 60 to electrically add two electrical sine waves of different frequencies (f,, f2) together to form the electrical drive voltage.
Although the present invention has been illustrated with reference to human applications, it should be understood by those skilled in the art of ultrasonic imaging that the present invention could also be used in a variety of applications in which the ultrasonic detection of fluids is contemplated. For example, the present invention could be used in animals, plant systems and in a variety of industrial flow processes. 5,601,086 7 8
Many modifications, improvements and substitutions will be apparent to the skilled artisan in view of the foregoing description without departing from the spirit and scope of the present invention as described in the specification and defined in the following claims. Thus, it is to be understood 5 that, within the scope of the appended claims, the invention may be practiced other than as spccifically described hereinabove.
is a receive transducer.
means for detecting the sum and difference frequencies.
6. The apparatus of claim 5 wherein the directing means for the ultrasonic energy at the first frequency is a transducer.
7.
The apparatus of claim 6 wherein the directing means for the ultrasonic energy at the second frequency is a kimducer.
The apparatus of claim 7 wherein the detecting means
What is claimed is:
9. An method for detecting the presence of ultrasonically 1, An apparatus for detecting the presence of ultrasoni-10 reflCCtiVe microsphere Contrast agents in a fluid, comprising:
cally relative microsphere contrast agents in a fluid, comdirecting ultrasonic energy into a region of the fluid at a prising:
first frequency, the first discrete frequency being means for directing ultrasonic energy into a region of the approximately at a resonant frequency of the microfluid at a first discrete frequency, the first frequency spheres in the range of 1 MHz-30 MHz; being approximately at a resonant frequency of the 15 simultaneously directing ultrasonic energy in to the region microspheres in the range of 1 MHz-30 MHz; of fluid at a second discrete frequency that is also an means for simultaneously directing ultrasonic energy into approximate resonant frequency of the microspheres, the region of fluid at a second discrete frequency that is wherein the microspheres in the fluid interact to emit also an approximate resonant frequency of the microsum and difference frequencies; and spheres, wherein the microspheres in the fluid interact 2o to emit sum and difference frequencies; and detecting the sum and difference frequencies. 10. A method for detecting the presence of ultrasonically reflective microsphere contrast agents in a body fluid, comprising the steps of: injecting microbubble contrast agents into a living body; directing ultrasonic energy into a region of the body fluid at a first discrete frequency, the first frequency being approximately at a resonant frequency of the microspheres in the range of 1 MHz-30 MHz; simultaneously directing ultrasonic energy into the body fluid region at a second discrete frequency that is also an approximate resonant frequency of the microspheres, such that the microspheres interact to emit sum and difference freauencies: and means for detecting the sum and difference frequencies.
2.
The apparatus of claim 1 wherein the directing means for the ultrasonic energy at the first frequency is a transducer. 25
3. The apparatus of claim 2 wherein the directing means for the ultrasonic energy at the second frequency is a transducer.
4.
The apparatus of claim 3 wherein the detecting means is a receive transducer.
5. An apparatus for measuring the presence of ultrasonically reflective microsphere contrast agents in a living body fluid, comprising: means for injecting microbubble contrast agents into a means for directing ultrasonic cnergy into a region of the body fluid at a first discrete frequency, the first frequency being approximately at a resonant frequency of the microspheres in the range of 1 MHz-30 MHz; means for simultaneously directing ultrasonic energy into 40 the region of body fluid at a second discrete frequency that is also an approximate resonant frequency of the microspheres, wherein the microspheres interact to emit sum and difference frequencies; and 30 living body; 35 detecting the mixed frequencies generated by interaction of the resonant microspheres with ultrasonic energy at the first and second frequencies. 11. A method for detecting the presence of ultrasonically reflective microsphere contrast agents in a body fluid as in claim 10 wherein said means for injecting microbubble contrast agents further comprise a means for injecting albumin-coated microbubble contrast agents. * * * * *
